Exploiting the Prevalence of Homologous Recombination Deficiencies in High-Grade Serous Ovarian Cancer

by Sara Bouberhan, Lauren Philp, Sarah Hill, Linah F Al-Alem, Bo Rueda
Published 2020-05-01

Integrated analysis of multiple microarray datasets identifies a reproducible survival predictor in ovarian cancer.

by Panagiotis A Konstantinopoulos, Stephen A Cannistra, Helen Fountzilas, Aedin Culhane, Kamana Pillay, Bo Rueda, Daniel Cramer, Michael Seiden, Michael Birrer, George Coukos, Lin Zhang, John Quackenbush, Dimitrios Spentzos
Published 2011-03-01

Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies

by Marina Stasenko, Evan Smith, Oladapo Yeku, Kay J. Park, Ian Laster, Kwangkook Lee, Sven Walderich, Elizabeth Spriggs, Bo Rueda, Britta Weigelt, Dmitriy Zamarin, Thapi Dharma Rao, David R. Spriggs
Published 2021-02-01